Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Clinical trial NCT00504400 · COMPLETED

Trial details

NCT number: NCT00504400
Sponsor: University Hospital, Bonn
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Idiopathic Macular Telangiectasia

Start date: 2007-08-01
Primary completion: 2009-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.